Mirum Pharmaceuticals Inc (MIRM) — Financial Flexibility Index
Mirum Pharmaceuticals Inc (MIRM) has a Financial Flexibility Index of -0.35x as of March 2026. Free cash flow of $-228.10 Million (operating CF $-228.76 Million minus capex $664.00K) represents 0% of total liabilities ($648.42 Million). Check Mirum Pharmaceuticals Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mirum Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Mirum Pharmaceuticals Inc across 8 annual periods. See Mirum Pharmaceuticals Inc (MIRM) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Mirum Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Mirum Pharmaceuticals Inc. For the full company profile including market capitalisation, see Mirum Pharmaceuticals Inc (MIRM) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | $56.78 Million | $55.83 Million | $528.12 Million | ▲ +322.8% |
| 2024 | 0.03x | $11.32 Million | $10.32 Million | $445.11 Million | ▲ +119.9% |
| 2023 | -0.13x | $-50.84 Million | $-70.94 Million | $397.95 Million | ▲ +77.5% |
| 2022 | -0.57x | $-119.86 Million | $-120.14 Million | $210.87 Million | ▲ +12.8% |
| 2021 | -0.65x | $-113.73 Million | $-132.76 Million | $174.44 Million | ▲ +49.5% |
| 2020 | -1.29x | $-88.85 Million | $-89.08 Million | $68.77 Million | ▲ +45.9% |
| 2019 | -2.39x | $-39.08 Million | $-39.36 Million | $16.36 Million | ▼ -2187.7% |
| 2018 | 0.11x | $7.13 Million | $-373.00K | $62.30 Million | — |